Supplementary Figure from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial

Authors :: Yi-Long Wu
Roy S. Herbst
Masahiro Tsuboi
Nenad Medic
Dakshayini Kulkarni
Lingmin Zeng
Shinji Atagi
Frances A. Shepherd
Manuel Domine
Laura Bonanno
Filippo de Marinis
Chong-Jen Yu
Charuwan Akewanlop
Kye Young Lee
Shanqing Li
Shun Lu
Huu Vinh Vu
Terufumi Kato
Sang-We Kim
Konstantin Laktionov
Christian Grohe
Thomas John
Jonathan W. Goldman
Margarita Majem
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Figure from Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial

Tools